Marsh
MRSH · What the business does, what can go wrong, and how options sellers approach it
What it does
Marsh is a global professional services firm that helps companies and institutions manage risk, people and strategy. It sits in two broad areas: risk and insurance services, and consulting.
In risk and insurance, Marsh is an insurance broker, and Guy Carpenter specializes in reinsurance. In consulting, Mercer advises on human resources, benefits and retirement, and Oliver Wyman is a management and economic consultancy.
How it makes money
Most revenue comes from fees and commissions. Brokers are typically paid commissions by insurers or fees by clients for placing coverage. Consulting units earn fees for advice, projects and ongoing services, and Mercer also earns revenue tied to the assets it manages or advises on. The firm does not take insurance underwriting risk, so it is paid for advice and distribution rather than for bearing claims.
Why investors own it
- Insurance and benefits are recurring needs, so revenue tends to be steadier than in many service businesses.
- Brokerage rewards scale and relationships, giving the largest firms advantages in data and global reach.
- Higher insurance prices can lift commission revenue.
- The firm earns fees for advice and placement rather than bearing insurance losses directly.
What can go wrong
- Softening insurance pricing reduces commissions.
- Consulting demand can weaken when clients cut discretionary spending.
- Lower interest rates can reduce investment income on funds held for clients.
- Errors and omissions claims are an inherent risk of giving advice.
- Competition is constant, and acquisitions can bring integration risk.
- Rules on broker compensation and conflicts of interest can change.
What to watch
- Organic revenue growth by segment
- Pricing trends in the property and casualty insurance market
- Operating margin trends
- Retention and new business in brokerage
- Mercer and Oliver Wyman demand and consulting bookings
- Acquisition activity and integration progress
- Capital returns through dividends and buybacks
Options income angle
Options on this stock are generally available across many strikes and expirations, with liquidity usually best in near-dated, near-the-money contracts.
Implied volatility tends to rise around quarterly earnings and when worries build about insurance pricing, the economy or financial stocks broadly. Otherwise premiums are often modest.
One caution for premium sellers: a defensive reputation does not prevent sharp earnings-day moves, and a short put can be assigned after a gap lower.
What the latest 10-K says
A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed February 9, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The filing in brief
Marsh grew revenue and operating income in 2025, but most of the revenue gain came from buying McGriff rather than from its existing business. Debt taken on for that deal raised interest costs, which held diluted earnings per share growth to 3%. The filing also flags softer insurance pricing and a three-year cost program (Thrive) as central to the year ahead.
How the business did
- Revenue was $27.0 billion, "an increase of 10%, or 4% on an underlying basis." Underlying revenue strips out currency moves and acquisitions. Operating income rose $406 million, or 7%, to $6.2 billion.
- Diluted earnings per share rose to $8.43 from $8.18. Interest expense was $960 million in 2025, compared to $700 million in 2024, due to debt raised to fund McGriff.
- Risk and Insurance Services revenue was $17.3 billion, up 12%, or 4% on an underlying basis. Its operating income margin was 26.8% versus 28.4%. Growth came from new business and renewals, partly offset by declining insurance and reinsurance premium rates. Interest earned on fiduciary funds (client money held temporarily) fell to $403 million from $497 million.
- Consulting revenue was $9.8 billion, up 7%, or 5% on an underlying basis. Within Mercer, Health and Wealth grew while Career declined 2% on an underlying basis.
- The company provided $5.3 billion of cash from operations, repurchased 10.1 million shares for $2.0 billion, and paid dividends of $1.7 billion. Restructuring costs were $222 million.
Risks specific to this company
- Uninsured professional claims: Marsh faces errors and omissions and breach of fiduciary duty claims, and may be unable to limit its liability through insurance in some jurisdictions. In many cases it has recorded no liability beyond legal fees because a loss is not yet probable and estimable.
- Pricing cycle: Much of the Risk and Insurance Services revenue is commission paid out of premiums, which Marsh does not set. The filing says the property and casualty market "has seen softer pricing recently, which may continue to impact profitability."
- Debt: Total consolidated debt was approximately $19.6 billion. The filing says this could limit flexibility for dividends, buybacks and acquisitions. Senior debt is rated A- by S&P, A3 by Moody's and A- by Fitch.
- Scrutiny of broker compensation: Payments from insurers outside normal fees and commissions were approximately 7% of Marsh Risk's revenue. The filing says these streams carry heightened regulatory, litigation and reputational risk.
- Overseas exposure: Approximately 51% of 2025 revenue came from outside the U.S., exposing results to exchange rates, sanctions rules and cash repatriation limits.
- U.K. tax dispute: The U.K. tax authority disallowed certain interest expense deductions for 2016-2020. Marsh has appealed, and resolution "may take several years."
What management is watching
- Thrive program: The three-year program is expected to cost approximately $500 million, with total annualized savings of approximately $400 million. Costs were $150 million in 2025, mostly severance.
- McGriff integration: Marsh expects approximately $250 million of further costs, mainly retention incentives, over the next 2 years. Acquisitions remain a key part of its strategy, with 20 completed in 2025.
- Capital return: In November 2025 the board authorized buying back up to $6 billion of stock. About $5.7 billion remained authorized at year-end, with no time limit.
- Pensions: No deficit funding is required for the U.K. plan sections until 2029 at the earliest. Management expects to contribute approximately $39 million to non-U.S. defined benefit plans in 2026.
- Measures to watch: Management points investors to non-GAAP underlying revenue, effective tax rate (23.6% in 2025) and the global minimum tax rules (Pillar Two).
What the latest 10-Q says
A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed October 15, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The quarter in brief
Marsh & McLennan reported third-quarter revenue of $6.9 billion, up 8%, or 5% on an underlying basis (a measure that strips out currency swings and acquisitions). Operating income was $1.2 billion, up 4%, and diluted earnings per share were $1.69, up 12%. Both were affected by one-time items: a $126 million remeasurement gain in revenue and a $144 million Greensill settlement charge, net of insurance proceeds.
How the business did
- Consolidated results: For the nine months, revenue was $21.9 billion, up 7%, or 5% underlying. Operating income was $4.9 billion, down 3%, and diluted earnings per share were $6.68, down 1%. Expenses grew faster than revenue, driven by higher base salaries and incentive compensation and by the Greensill charges.
- Risk and Insurance Services: Segment revenue was $4.2 billion, up 7%, or 3% underlying. Operating income was $745 million, against $750 million a year earlier. Risk grew 5% underlying on higher new business and renewal revenue, partly offset by declining insurance premium rates. Reinsurance revenue fell 6% to $374 million, mainly on declining reinsurance premium rates.
- Consulting: Revenue was $2.7 billion, up 9%, or 8% underlying, and operating income rose to $563 million from $501 million. Management Consulting grew 14% on both a reported and underlying basis. Investments and Retirement rose 8% underlying, while Workforce and Rewards fell 1%.
- Unusual items and capital: The Greensill charge was $569 million for the nine months. In July the company bought the remaining 60% of Deasterra Partners, S.L., a Spain-based insurance broker, and booked the $126 million gain. Operating cash flow for the nine months was $2.3 billion, against $3.1 billion a year earlier. The company repurchased approximately 2.7 million shares for $500 million in the quarter and declared a quarterly dividend of $0.990 per share.
What management is watching
- Thrive restructuring program: The company raised the expected program cost from $500 million to approximately $750 million and expected annualized savings from $400 million to approximately $600 million. It expects savings and charges to be evenly distributed over the program period. Restructuring costs were $79 million in the quarter.
- Outside pressures: Management points to the conflict in the Middle East, tariffs, slower GDP growth or recession, lower interest rates, currency moves and changes in insurance premium rates. Lower rates already cut interest earned on fiduciary funds to $100 million from $109 million. The filing gives no full-year revenue or profit outlook.
- Spending and capital: The company completed 8 acquisitions in 2026 for a total purchase consideration of $550 million. It has about $3.7 billion left on its share repurchase authorization and had $1.6 billion of commercial paper outstanding at September 30, 2026.
- Measures to watch: Management points investors to non-GAAP underlying revenue growth, which it uses internally to compare periods and allocate resources.
Follow MRSH in Kortex
The Kortex app shows MRSH's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.